GL1X · GenesisL1 explorer

MolNFT v1 · #16030 · protein

Extendend tethering: in situ assembly of inhibitors

1NMQ · Caspase-3: “Extendend tethering: in situ assembly of inhibitors”. X-ray diffraction, 1 ligand (160), 4 pockets (best druggability 0.65). MolNFT v1 #16030 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1NMQ
Type
protein
Length
476 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Caspase-3
EC
3.4.22.-
UniProt
P42574
Ligands
160
Pockets
4 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 28% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCaspase-3 (EC 3.4.22.-)protein23828% helix, 26% strandP42574

Ligands and binding sites

  • 160 · 3-(3-{2-[(5-methanesulfonyl-thiophene-2-carbonyl)-amino]-ethyldisulfanylmethyl}- benzenesulfonylamino)-4-oxo-pentanoic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13110.650.8035empty
22170.480.7539160
32220.480.7432160
4670.330.7515empty

Interfaces

1 interface between chains.

  • A–B · 2413 Ų buried · 41 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 1NMQ · Extendend Tethering: In Situ Assembly of Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • P42574 · AlphaFold monomer V2.0 prediction for caspase-3 (P42574) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.